Supplement Industry Offers Cautionary Tale For Mandatory Cosmetic GMPs
This article was originally published in The Rose Sheet
Executive Summary
Roughly six years after publication of FDA’s final rule establishing mandatory Good Manufacturing Practices in the dietary supplement sector, the industry’s noncompliance rate was still at nearly 70% in fiscal 2013, according to FDA data. How GMP requirements are laid out in forthcoming federal legislation to update FDA’s cosmetics oversight program could dictate the potential challenge before industry.
You may also be interested in...
Senate Health Committee Releases Cosmetics Reform Discussion Draft
2017 In Review: FDA's Cosmetics Slowdown Could Bolster Case For Legislative Jumpstart
FDA's cosmetics activities fell off noticeably compared with 2016, and the change in the White House spurred the agency to begin looking for regulatory burdens to eliminate while shuffling priorities away from cosmetics to make do with proposed cuts in federal funding. In this climate, robust cosmetics oversight may depend on a legislative update, with multiple draft bills on the table.
Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims
Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
